|
Volumn 30, Issue 4, 2008, Pages 18-25
|
Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA INTERFERON;
IMMUNOLOGIC FACTOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
CHEMICALLY INDUCED DISORDER;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG MONITORING;
DRUG SELF ADMINISTRATION;
FEVER;
HEADACHE;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
MOTIVATION;
MULTIPLE SCLEROSIS;
NURSE;
NURSE ATTITUDE;
NURSING;
ORGANIZATION AND MANAGEMENT;
PATIENT COMPLIANCE;
PATIENT EDUCATION;
PSYCHOLOGICAL ASPECT;
REVIEW;
RISK FACTOR;
SOCIAL SUPPORT;
SUBCUTANEOUS DRUG ADMINISTRATION;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
DRUG ADMINISTRATION SCHEDULE;
DRUG MONITORING;
DRUG THERAPY, COMBINATION;
FEVER;
HEADACHE;
HUMANS;
IMMUNOLOGIC FACTORS;
INJECTIONS, INTRAMUSCULAR;
INJECTIONS, SUBCUTANEOUS;
INTERFERON-BETA;
MEDICATION ADHERENCE;
MOTIVATION;
MULTIPLE SCLEROSIS;
NURSE CLINICIANS;
NURSE'S ROLE;
PATIENT EDUCATION AS TOPIC;
RISK FACTORS;
SELF ADMINISTRATION;
SOCIAL SUPPORT;
|
EID: 61949261269
PISSN: 19137176
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (26)
|
References (49)
|